Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lonza unveils new GS Xceed Gene Expression System
The GS Xceed system was shown to reduce cell line development timelines by up to six weeks over the existing CHOK1SV based system and has achieved titers of
The GS Xceed system was shown to reduce cell line development timelines by up to six weeks over the existing CHOK1SV based system and has achieved titers of
The starting point for the development of proprietary analogs in the collaboration is VS-507, a proprietary formulation of salinomycin. Verastem’s Wnt signaling and cancer stem cell assays will
Emerson accomplished installation of its PlantWeb digital plant architecture at the three plants, including DeltaV digital automation systems, Rosemount measurement instruments, and AMS Suite predictive maintenance software. Jubilant
Ranbaxy wants to go ahead with its expansion plans though American regulators blocked imports of company’s 31 medicines over quality issues. The company is also considering to start
The company has incorporated the Affymetrix GCS3000, Sequenom MassArray, and LifeTech Ion Torrent technologies to recognise polymorphisms involved in drug response and adverse drug events as well as
The multi-centre, first-in-human trial, will enrol 64 patients to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and anticancer activity of the TAP compound. ImmunoGen vice president and chief medical
The new service platform, which is aimed at the identification of novel ligands for client-driven drug targets, will involve multi-stage screening of targets against a complex combinatorial peptoid
The oral modified release ibuprofen formulation is based on the company’s CDT controlled delivery technology platform, designed for the programmed release of active pharmaceutical ingredients and nutritional products.
Robitussin DM product contains Dextromethorphan HBr 15mg and Guaifenessin 100mg per 5ml. FDA officer-in-charge and assistant secretary of health Nicolas Lutero III said the continuous distribution of the
Pomaglumetad methionil did not separate from placebo in the primary efficacy endpoint in either the overall or predefined genetic subpopulation at the two doses investigated (40mg and 80mg